NIH – MPP, COVID-19 Patent and Biological Material License Agreement

• Post author:GHIAA Admin
• Post published:June 29, 2022
• Post category:

Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement

Boston University Startup Exclusive License Template

• Post author:GHIAA Admin
• Post published:June 6, 2022
• Post category:

Continue ReadingBoston University Startup Exclusive License Template

Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement

• Post author:GHIAA Admin
• Post published:May 31, 2022
• Post category:

Continue ReadingElkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement

BMGF – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement

• Post author:GHIAA Admin
• Post published:April 26, 2022
• Post category:

Continue ReadingBMGF – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement

Gavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement

• Post author:GHIAA Admin
• Post published:April 12, 2022
• Post category:

Continue ReadingGavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement

CEPI – CureVac, Framework Partnering Agreement

• Post author:GHIAA Admin
• Post published:March 31, 2022
• Post category:

Continue ReadingCEPI – CureVac, Framework Partnering Agreement

CEPI – Dynavax, COVID-19 Material Reservation Agreement

• Post author:GHIAA Admin
• Post published:January 28, 2022
• Post category:

Continue ReadingCEPI – Dynavax, COVID-19 Material Reservation Agreement

University of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement

• Post author:GHIAA Admin
• Post published:January 11, 2022
• Post category:

Continue ReadingUniversity of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement

MSD – MPP, Molnupiravir License Agreement

• Post author:GHIAA Admin
• Post published:November 22, 2021
• Post category:

Continue ReadingMSD – MPP, Molnupiravir License Agreement